Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Primary Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced Pd-catalyzed synthesis of aromatic primary amines from OTf precursors. Offers superior safety, purity, and cost efficiency for pharmaceutical supply chains.
Patent CN88101658A reveals a Ni-Ru-M catalyst for high-selectivity reductive amination, offering cost-effective amine production and supply chain stability.
Patent CN103130652B enables metal-free phenol to amine conversion. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains significantly.
Patent CN103739417A details a green aqueous copper-catalyzed amination. Offers cost reduction in pharmaceutical intermediate manufacturing with recyclable systems.
Patent CN101346345B details a selective primary amine synthesis using ammonia and formaldehyde, offering high purity and cost efficiency for pharmaceutical intermediates manufacturing.
Novel ruthenium pincer catalyst enables direct amine synthesis from alcohols. Reduces waste and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108299214B enables high-selectivity amino compound separation using novel chemistry. Reduces operational costs and simplifies supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103058875A details a novel Fe-ZrO2-MnO2 catalyzed route for N1923. Achieves higher yields and lower temperatures for cost-effective extractant manufacturing.
Patent CN101547890A details a catalytic asymmetric synthesis of primary amines using spiroboronic esters, offering high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN105622304B offers derivatization method reducing genotoxic impurities below 2ppm ensuring supply chain reliability and cost efficiency.
Patent CN103965057A reveals a copper-catalyzed reduction method offering high purity and safety. Ideal for cost reduction in fine chemical manufacturing and supply chain reliability.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN101765579A reveals a safer, high-yield route for beta-nitrostyrene compounds using primary amines. Discover cost-effective manufacturing solutions for pharmaceutical intermediates.
Patent CN101765579A details a safe acetic acid method for beta-nitrostyrene. Offers cost reduction in pharma intermediate manufacturing with high purity.
Patent CN101765579A reveals a safer acetic acid method for beta-nitrostyrene intermediates, offering high yield and reduced thermal risk for pharma supply chains.
Patent CN115448841A reveals a cost-effective silver-catalyzed method for synthesizing primary amines using ammonia water, offering significant advantages for pharmaceutical intermediate manufacturing.
Novel cyclic imide method for primary amines. Reduces waste, enhances supply chain reliability for pharmaceutical intermediates and fine chemical manufacturing.
Novel radical amino migration patent enables mild benzolactam synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Discover a green, high-yield method for 2-alkynyl indole synthesis using water as solvent. Reduce production costs and supply chain risks with our CDMO expertise.